Deerfield Management as of Sept. 30, 2013
Portfolio Holdings for Deerfield Management
Deerfield Management holds 107 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cubist Pharmaceuticals | 6.1 | $131M | 2.1M | 63.55 | |
| Dendreon Corp note | 5.1 | $110M | 177M | 0.62 | |
| NxStage Medical | 3.1 | $66M | 5.0M | 13.16 | |
| Array BioPharma | 3.1 | $66M | 11M | 6.22 | |
| Nuvasive Inc. conv | 2.9 | $62M | 64M | 0.97 | |
| Pfizer (PFE) | 2.4 | $52M | 1.8M | 28.73 | |
| Volcano Corporation note 1.750%12/0 | 2.4 | $52M | 50M | 1.03 | |
| AstraZeneca (AZN) | 2.2 | $48M | 928k | 51.93 | |
| Teva Pharmaceutical Industries (TEVA) | 2.2 | $47M | 1.2M | 37.78 | |
| Auxilium Pharmaceuticals | 2.1 | $45M | 2.5M | 18.20 | |
| Abbvie (ABBV) | 2.1 | $45M | 1.0M | 44.73 | |
| Allergan | 2.0 | $44M | 485k | 90.45 | |
| Integra Lifesciences Holdings conv bnd | 2.0 | $42M | 42M | 1.02 | |
| Keryx Biopharmaceuticals | 1.8 | $39M | 3.8M | 10.09 | |
| Infinity Pharmaceuticals (INFIQ) | 1.8 | $38M | 2.2M | 17.43 | |
| Hologic Inc cnv | 1.8 | $38M | 38M | 1.01 | |
| Intermune Inc note 2.500% 9/1 | 1.7 | $37M | 42M | 0.90 | |
| Forest Laboratories | 1.7 | $36M | 845k | 42.79 | |
| Mylan | 1.6 | $35M | 928k | 38.17 | |
| Antares Pharma | 1.6 | $35M | 8.7M | 4.06 | |
| Air Methods Corporation | 1.6 | $34M | 806k | 42.56 | |
| Exelixis Inc cnv | 1.6 | $34M | 29M | 1.16 | |
| Thoratec Corporation | 1.6 | $33M | 891k | 37.29 | |
| Tenet Healthcare Corporation (THC) | 1.5 | $33M | 788k | 41.19 | |
| Dyax | 1.4 | $30M | 4.4M | 6.86 | |
| Community Health Systems (CYH) | 1.4 | $30M | 712k | 41.50 | |
| Brookdale Senior Living note | 1.4 | $29M | 25M | 1.17 | |
| Momenta Pharmaceuticals | 1.3 | $29M | 2.0M | 14.39 | |
| Flamel Technologies | 1.3 | $28M | 4.3M | 6.56 | |
| Tornier Nv | 1.3 | $28M | 1.5M | 19.33 | |
| XOMA CORP Common equity shares | 1.3 | $27M | 6.1M | 4.49 | |
| Pacific Biosciences of California (PACB) | 1.2 | $27M | 4.9M | 5.52 | |
| AngioDynamics (ANGO) | 1.2 | $27M | 2.0M | 13.20 | |
| Array Biopharma Inc note 3.000% 6/0 | 1.2 | $27M | 23M | 1.15 | |
| XenoPort | 1.2 | $26M | 4.6M | 5.68 | |
| Onconova Therapeutics | 1.2 | $26M | 968k | 26.47 | |
| Spectrum Pharmaceuticals | 1.2 | $25M | 3.0M | 8.38 | |
| Alnylam Pharmaceuticals (ALNY) | 1.1 | $25M | 383k | 64.01 | |
| Aetna | 1.1 | $23M | 353k | 64.02 | |
| Merck & Co (MRK) | 1.1 | $23M | 475k | 47.61 | |
| Ariad Pharmaceuticals | 1.1 | $23M | 1.2M | 18.40 | |
| Universal American | 1.0 | $22M | 2.9M | 7.62 | |
| Capital Senior Living Corporation | 1.0 | $22M | 1.1M | 21.15 | |
| Accuray Inc Del note 3.750% 8/0 | 1.0 | $22M | 21M | 1.04 | |
| Prosensa Hldgs B V Shs Usd | 1.0 | $21M | 3.2M | 6.61 | |
| Globus Med Inc cl a (GMED) | 1.0 | $21M | 1.2M | 17.46 | |
| Sagent Pharmaceuticals | 1.0 | $21M | 1.0M | 20.40 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $18M | 845k | 21.46 | |
| Pharmacyclics | 0.8 | $18M | 127k | 138.26 | |
| Cardinal Health (CAH) | 0.8 | $17M | 325k | 52.15 | |
| Molina Healthcare (MOH) | 0.8 | $16M | 459k | 35.60 | |
| Insmed (INSM) | 0.7 | $15M | 931k | 15.61 | |
| BioDelivery Sciences International | 0.7 | $14M | 2.6M | 5.43 | |
| Edwards Lifesciences (EW) | 0.7 | $14M | 200k | 69.63 | |
| Questcor Pharmaceuticals | 0.6 | $14M | 234k | 58.00 | |
| Dendreon Corp cnv | 0.6 | $13M | 14M | 0.96 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $12M | 1.6M | 7.28 | |
| Bluebird Bio (BLUE) | 0.5 | $11M | 423k | 26.96 | |
| DepoMed | 0.5 | $11M | 1.5M | 7.47 | |
| BioScrip | 0.5 | $11M | 1.2M | 8.78 | |
| Itmn 2 1/2 12/15/17 | 0.5 | $11M | 7.5M | 1.40 | |
| Nanosphere | 0.5 | $10M | 5.1M | 2.00 | |
| Cempra | 0.4 | $9.2M | 804k | 11.50 | |
| Mei Pharma | 0.4 | $9.2M | 822k | 11.25 | |
| Vanda Pharmaceuticals (VNDA) | 0.4 | $9.0M | 820k | 10.95 | |
| Zogenix | 0.4 | $8.3M | 4.5M | 1.85 | |
| Cross Country Healthcare (CCRN) | 0.4 | $8.1M | 1.3M | 6.04 | |
| Alphatec Holdings | 0.4 | $7.8M | 4.0M | 1.97 | |
| Accuray Inc note 3.500% 2/0 | 0.3 | $7.5M | 5.0M | 1.50 | |
| Liposcience | 0.3 | $6.9M | 1.4M | 5.00 | |
| Anthera Pharmaceutcls | 0.3 | $6.8M | 1.7M | 4.02 | |
| Arena Pharmaceuticals | 0.3 | $6.4M | 1.2M | 5.27 | |
| Alere Inc note 3.000% 5/1 | 0.3 | $6.0M | 5.8M | 1.05 | |
| Ovascience | 0.3 | $6.0M | 608k | 9.91 | |
| Nanostring Technologies (NSTGQ) | 0.2 | $5.5M | 497k | 11.00 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $4.7M | 100k | 47.23 | |
| CAS Medical Systems | 0.2 | $4.3M | 3.2M | 1.34 | |
| Agios Pharmaceuticals (AGIO) | 0.2 | $4.2M | 151k | 27.96 | |
| Express Scripts Holding | 0.2 | $4.0M | 65k | 61.80 | |
| Rigel Pharmaceuticals (RIGL) | 0.2 | $3.8M | 1.1M | 3.58 | |
| Therapeuticsmd | 0.2 | $3.7M | 1.3M | 2.93 | |
| Novavax | 0.2 | $3.4M | 1.1M | 3.15 | |
| Synageva Biopharma | 0.1 | $3.2M | 50k | 63.40 | |
| Portola Pharmaceuticals | 0.1 | $3.2M | 119k | 26.75 | |
| Sequenom | 0.1 | $2.6M | 985k | 2.67 | |
| LCA-Vision | 0.1 | $2.6M | 731k | 3.60 | |
| Durata Therapeutics | 0.1 | $2.5M | 276k | 9.04 | |
| Auxilium Pharmaceuticals note | 0.1 | $2.6M | 2.5M | 1.03 | |
| Discovery Laboratories | 0.1 | $2.3M | 1.2M | 1.96 | |
| Mannkind Corp note 3.750%12/1 | 0.1 | $2.1M | 2.1M | 0.99 | |
| Dendreon Corporation | 0.1 | $2.1M | 700k | 2.93 | |
| Hologic (HOLX) | 0.1 | $2.0M | 96k | 20.65 | |
| Elan Corporation | 0.1 | $1.6M | 100k | 15.58 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $1.2M | 100k | 11.84 | |
| Palatin Technologies | 0.1 | $1.4M | 2.0M | 0.69 | |
| Baxter International (BAX) | 0.1 | $985k | 15k | 65.67 | |
| GTx | 0.1 | $1.0M | 500k | 2.03 | |
| Mast Therapeutics | 0.1 | $1.2M | 2.6M | 0.44 | |
| Solta Medical | 0.0 | $702k | 339k | 2.07 | |
| AVANIR Pharmaceuticals | 0.0 | $656k | 155k | 4.23 | |
| Endocyte | 0.0 | $672k | 50k | 13.33 | |
| Catamaran | 0.0 | $574k | 13k | 45.92 | |
| Sophiris Bio | 0.0 | $578k | 124k | 4.68 | |
| Bruker Corporation (BRKR) | 0.0 | $434k | 21k | 20.67 | |
| Bacterin Intl Hldgs | 0.0 | $517k | 772k | 0.67 | |
| Orexigen Therapeutics | 0.0 | $138k | 23k | 6.11 | |
| Icad (ICAD) | 0.0 | $205k | 39k | 5.27 |
